|
|
Hearings -
Subcommittee on Oversight and Investigations
|
|
Tuesday, 16 June 2009 09:58 |
|
The Subcommittee on Oversight and Investigations held a hearing entitled "Terminations of Individual Health Policies by Insurance Companies" on Tuesday, June 16, 2009 in room 2123 Rayburn House Office Building. The hearing examined the practice of "post-claims underwriting," which occurs when insurance companies cancel individual health insurance policies after providers submit claims for medical services rendered.
|
|
Read more...
|
|
|
Hearings -
Subcommittee on Oversight and Investigations
|
|
Friday, 12 June 2009 08:12 |
|
The Oversight and Investigations Subcommittee, chaired by Rep. Bart Stupak (D-MI) held a hearing at 10 a.m. on Friday, June 12, 2009 to examine the recent auto dealership closures announced by Chrysler and General Motors.
|
|
Read more...
|
|
Hearings -
Subcommittee on Oversight and Investigations
|
|
Thursday, 04 June 2009 08:04 |
|
The Subcommittee on Oversight and Investigations held a hearing titled, "Commercial Sales of Military Technologies" on Thursday, June 4, 2009, in 2322 Rayburn House Office Building. The hearing examined the commercial sales of sensitive technology with military applications and provide the results of a Government Accountability Office investigation on this issue.
|
|
Read more...
|
|
Hearings -
Subcommittee on Oversight and Investigations
|
|
Tuesday, 21 April 2009 08:22 |
|
The Subcommittee on Oversight and Investigations held a hearing titled, “Secrecy in the Response to Bayer’s Fatal Chemical Plant Explosion,” at 12:00 p.m., on Tuesday, April 21, 2009, in 2322 Rayburn House Office Building.
|
|
Read more...
|
|
Hearings -
Subcommittee on Oversight and Investigations
|
|
Thursday, 26 March 2009 14:33 |
|
The Subcommittee on Oversight and Investigations held a hearing titled, “Institutional Review Boards that Oversee Experimental Human Testing for Profit” at 10:00 a.m. on Thursday, March 26, 2009, in 2123 Rayburn House Office Building. The hearing examined whether institutional review boards (IRBs) and the federal government are adequately protecting human subjects of biomedical research.
|
|
Read more...
|
|
|
<< Start < Prev 1 2 3 4 5 Next > End >>
|
|
Page 4 of 5 |